Patients diagnosed with
Alzheimer’s Disease (AD) will most
likely be treated with what UCL
professor of neuroscience John
Hardy called a “cocktail of disease modifying
drugs”, at the annual
University College London School of
Pharmacy lecture recently.
The drugs will contribute to a
slowing of the disease as opposed
to a reversal as they tackle the
three mechanisms of pathology.
The first is the build up of amyloid
plaques; second is a recently
discovered set of genes which
determine how the brain breaks
down amyloid; third is a set of
genes involved in brain cholesterol.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jan 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.